The β-catenin destruction multiprotein complex negatively regulates the canonical Wnt signalling pathway by targeting β-catenin for ubiquitination and proteasomal degradation. The complex includes axin, adenomatosis polyposis coli (APC), protein phosphatase 2A (PP2A) and glycogen synthase kinase 3 (GSK3).

1. Callahan N, Modesto A, Meira R, Seymen F, Patir A, Vieira AR. (2009) Axis inhibition protein 2 (AXIN2) polymorphisms and tooth agenesis. Arch Oral Biol, 54 (1): 45-9. [PMID:18790474]

2. Cheng LZ, Huang DL, Tang ZR, Zhang JH, Xiong T, Zhou C, Zhang NX, Fu R, Cheng YX, Wu ZQ. (2023) Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer. Br J Pharmacol, 180 (23): 3071-3091. [PMID:37461816]

3. Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. (2004) Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet, 74 (5): 1043-50. [PMID:15042511]

4. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C et al.. (2000) Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet, 26 (2): 146-7. [PMID:11017067]

5. Marvin ML, Mazzoni SM, Herron CM, Edwards S, Gruber SB, Petty EM. (2011) AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am J Med Genet A, 155A (4): 898-902. [PMID:21416598]